Staffing: 2024’s Biggest Lab Operations Challenge
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
ADLM president Anthony Killeen looks at labs’ staffing struggles in 2024 and what can be done to alleviate them in the coming year
Companies in the COVID-19 diagnostic products market will need to decide whether to wind down their EUA-based investments.
Though Q4 earnings in the lab industry took a beating as predicted, the earnings picture wasn’t nearly as bleak as many had feared.
The health plan issued a new policy expanding coverage of molecular genetic tests for personalized cancer diagnosis, prognosis, and treatment.
Genomics software developer Allelica to collaborate with Taiwanese precision medicine firm to develop a multi-ancestry breast cancer test.
Economic volatility and uncertainty is also making a significant impact on merger and acquisition activity in the diagnostics space.
An effective business case communicates need, benefit, and risks.
Abbott and Roche garnered the lion’s share of new 510(k) lab test approvals in 2022.
There were three notable CDx alliances announced in January 2023, all of which involved cancer-related solutions.
According to a new report, tough macro-economic conditions caused digital health fundraising levels to fall off dramatically in 2022.
Factors to consider when determining if the concierge business model is best for your laboratory.